Australia markets close in 27 minutes

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.0000+0.0900 (+1.83%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 38.75M
Enterprise value 54.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.22
Price/book (mrq)1.55
Enterprise value/revenue 3.12
Enterprise value/EBITDA -21.13

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 31.21%
S&P500 52-week change 323.57%
52-week high 36.0500
52-week low 34.2600
50-day moving average 35.1500
200-day moving average 35.0387

Share statistics

Avg vol (3-month) 37.76k
Avg vol (10-day) 38.21k
Shares outstanding 57.75M
Implied shares outstanding 67.81M
Float 85.6M
% held by insiders 127.78%
% held by institutions 113.23%
Shares short (15 Apr 2024) 44.47k
Short ratio (15 Apr 2024) 40.52
Short % of float (15 Apr 2024) 40.07%
Short % of shares outstanding (15 Apr 2024) 40.06%
Shares short (prior month 15 Mar 2024) 46.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 325 July 1990

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -33.05%
Operating margin (ttm)-9.35%

Management effectiveness

Return on assets (ttm)-7.36%
Return on equity (ttm)-20.86%

Income statement

Revenue (ttm)17.47M
Revenue per share (ttm)2.26
Quarterly revenue growth (yoy)30.30%
Gross profit (ttm)N/A
EBITDA -2.5M
Net income avi to common (ttm)-5.77M
Diluted EPS (ttm)-0.7500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)978.74k
Total cash per share (mrq)0.13
Total debt (mrq)16.69M
Total debt/equity (mrq)66.78%
Current ratio (mrq)2.73
Book value per share (mrq)3.22

Cash flow statement

Operating cash flow (ttm)-4.67M
Levered free cash flow (ttm)-4.51M